Search Results - "TANAKA, Teruji"

Refine Results
  1. 1

    Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient by Kato, Takanobu, Furusaka, Akihiro, Miyamoto, Michiko, Date, Tomoko, Yasui, Kotaro, Hiramoto, Jun, Nagayama, Kazuo, Tanaka, Teruji, Wakita, Takaji

    Published in Journal of medical virology (01-07-2001)
    “…Although hepatitis C virus (HCV) is a major cause of non‐A non‐B hepatitis, its pathogenic role in fulminant hepatitis remains controversial. A 32‐year‐old man…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Hepatitis C Virus Infection in Patients with B-cell Non-Hodgkin's Lymphoma by MIZOROGI, Fumi, HIRAMOTO, Jun, NOZATO, Akiyo, TAKEKUMA, Yoshifusa, NAGAYAMA, Kazuo, TANAKA, Teruji, TAKAGI, Keizo

    Published in Internal Medicine (2000)
    “…Objective As a causative role of hepatitis C virus (HC V) in B-cell lymphoproliferative disorders (LPD) has been suggested by several reports, we investigated…”
    Get full text
    Journal Article
  4. 4

    The Production of Colony-Stimulating Factors by Thyroid Carcinoma Is Associated with Marked Neutrophilia and Eosinophilia by NAKADA, Tetsuya, SATO, Hiromitsu, INOUE, Fuyuhiko, MIZOROGI, Fumi, NAGAYAMA, Kazuo, TANAKA, Teruji

    Published in Internal Medicine (1996)
    “…Cancers producing colony-stimulating factors and associated with marked leukocytosis are relatively rare. We report here a case of a thyroid cancer producing…”
    Get full text
    Journal Article
  5. 5

    Findings of Portal Hypertensive Gastroenteropathy Using Infrared Electronic Endoscopy by NARIMIYA, Norichika, JOKI, Mari, SATO, Hiromitsu, SUGIMOTO, Izumi, TANAKA, Teruji

    Published in Digestive endoscopy (01-04-1999)
    “…: The aim of this study was to ascertain how and in what form portal hypertensivive gastroenteropathy affects the submucosal vasculature using an infrared…”
    Get full text
    Journal Article
  6. 6

    Gastric Ulcer Hemorrhage Treated by Endoscopic Hemostasis with Histoacryl by JOKI, Mari, NARIMIYA, Norichika, KUNIHIRO, Naoko, HAMADA, Hiroko, ITO, Yoshihiro, MARUYAMA, Tatsushi, MIYAJIMA, Hiroto, SATO, Hiromitsu, ODAGIRI, Masayoshi, SUGIMOTO, Izumi, WATANABE, Toshiaki, NAKADA, Tetsuya, TANAKA, Teruji

    Published in Digestive endoscopy (01-10-1997)
    “…: We report a case of hemorrhagic gastric ulcer in which endoscopic injection of Histoacryl effectively achieved hemostasis. The patient was an 86‐year‐old…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic function by Ueno, H, Kondo, E, Yamamoto-Honda, R, Tobe, K, Nakamoto, T, Sasaki, K, Mitani, K, Furusaka, A, Tanaka, T, Tsujimoto, Y, Kadowaki, T, Hirai, H

    Published in Molecular biology of the cell (01-02-2000)
    “…Insulin receptor substrate (IRS) proteins are docking proteins that couple growth factor receptors to various effector molecules, including phosphoinositide-3…”
    Get full text
    Journal Article
  11. 11

    Fluoroscopic contrast medium percutaneous ethanol injection therapy (FCM-PEIT): newly developed clinical useful method for injecting ethanol into nodules of hepatocellular carcinoma by Komiyama, K, Takekuma, Y, Nekohashi, T, Abe, T, Satoi, J, Kanesaki, A, Ui, T, Morimoto, S, Tanaka, T

    Published in Nippon Shōkakibyō Gakkai zasshi (01-02-1994)
    “…We have performed fluoroscopic contrast medium percutaneous ethanol injection therapy (FCM-PEIT) total 266 times to 82 hepatocellular carcinoma (HCC) nodules…”
    Get more information
    Journal Article
  12. 12

    Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis by Inoue, Tomoo, Ohnishi, Akihiro, Matsuo, Atsushi, Kawai, Bunpei, Kunihiro, Naoko, Tada, Yoshiki, Koizumi, Fumiaki, Chau, Tommy, Okada, Keizo, Yamamura, Yoshitaka, Tanaka, Teruji

    Published in Clinical pharmacology and therapeutics (01-05-1998)
    “…Objective Progressive cirrhosis is associated with increasing difficulty to handle free water. We examined the therapeutic potential of an orally active…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects by Ohnishi, A, Mihara, M, Kamakura, H, Tomono, Y, Hasegawa, J, Yamazaki, K, Morishita, N, Tanaka, T

    Published in Journal of clinical pharmacology (01-11-1993)
    “…E2020, a central-acting cholinesterase inhibitor, is now under clinical development as a potential therapeutic agent for senile dementia of Alzheimer type. In…”
    Get more information
    Journal Article
  19. 19

    Human Butyrylcholinesterase L330I Mutation Belongs to a Fluoride-Resistant Gene, by Expression in Human Fetal Kidney Cells by Sudo, Kayoko, Maekawa, Masato, Akizuki, Setsuko, Magara, Tadao, Ogasawara, Hisataka, Tanaka, Teruji

    “…We noticed a Japanese male showed low serum butyrylcholinesterase(BCHE) activity on health examination. The phenotyping analysis revealed a reduced dibucaine…”
    Get full text
    Journal Article
  20. 20